Keywords: MAPT; PARK2; GBA; PINK1; LRRK2;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ApoE; apolipoprotein E; CCD; crossed cerebellar diaschisis; ECD; Tc-ethyl cysteinate dimer; eZIS; easy Z-score imaging system; MAPT; microtubule-associated protein tau; MMSE; mini-mental state examination; MRA; magnetic resonance angiography; MRI; magneti
Keywords: Act-D; actinomycin-D; ACTB; actin-b; AD; Alzheimer's disease; AT8; Tau epitope with phosphorylated Ser202/Thr205 residues; CNS; central nervous system; DAPI; 4â²,6-diamidino-2-phenylindole; DFC; dense fibrillar component (of the nucleolus); EDTA; ethylen
Keywords: AD; Alzheimer's disease; Aβ; β-amyloid peptide; NFTs; neurofibrillary tangles; EOAD; early-onset AD; LOAD; late-onset AD; OMOT; One-molecule-one-target; ROS; reactive oxygen species; CDMT; Combination-drugs-multi-targets; BBB; blood brain barrier; DDT;
Keywords: Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: AD; Alzheimer Disease; DS; Down Syndrome; Aβ; amyloid-β; HSA21; Chromosome 21; APP; Amyloid precursor protein; BACE1/2; β-site APP cleaving enzyme 1/2; βCTF; β carboxyl-terminal fragment; PSEN1; presenilin 1; APPL1; adaptor protein containing pleckst
Keywords: 3-MC; 3-methylcholanthrene; Ah; aryl hydrocarbon; AhE; aryl hydrocarbon receptor; AP-1; activator protein-1; ARE; antioxidant response element; ATF4; activating transcription factor 4; β-NF; β-naphthoflavone; β-NF-RE; β-NF-responsive element; β-TRCP;
Keywords: 6-OHDA; 6-hydroxydopamine; Aβ; amyloid-β; AD; Alzheimer disease; ALS; amyotrophic lateral sclerosis; APOE4; apolipoprotein E4; APP; amyloid precursor protein; ASCL1; achaete-scute family basic helix-loop-helix transcription factor 1; ATP; adenosine trip
Keywords: Aging; Nuclear tau; AT100; Alzheimer disease; Neurons; Epithelial cells; Colorectal mucosa; Breast acinar cells; Cancer; Confocal microscopy; Aging marker; AD; Alzheimer's disease; ADI-ADIV; Stages of AD following Braak and Braak (1991) classification;
Keywords: Traumatic brain injury; Chronic traumatic encephalopathy; Tauopathy; Concussion; Repetitive head injury; 2-AG; 2-arachidonoylglycerol; 3-NT; 3-nitrotyrosine; 4-HNE; 4-hydroxynonenal; Ach; acetylcholine; AChEI; acetylcholine esterase inhibitor; AD; Alzheim
Keywords: AAO; age at onset; CIs; confidence intervals; GBA; glucocerebrosidase; LRRK2; leucine-rich repeat kinase 2; MAPT; microtubule-associated protein tau; NOS; Newcastle-Ottawa Scale; ORs; odds ratios; PD; Parkinson's disease; SNCA; a-Synuclein; meta-analy
Keywords: APP; amyloid precursor protein; ATF; activating transcription factor 6; CREB; cAMP response element binding protein; EC; enriched condition; EDTA; ethylenediaminetetraacetic acid; ERK; extracellular signal regulated kinase; FR1; fixed ratio 1; GO; Gene On
Keywords: Progressive supranuclear palsy; MAPT; p.S285R; tau pathology
Keywords: Tau; Adult neurogenesis; hTau; Mouse; Tauopathy; MAPT;
Keywords: AD; Alzheimer's disease; Aβ; amyloid β; Aph-1; anterior pharynx defective 1; AP; adaptor protein; APOE; apolipoprotein E; APP; amyloid precursor protein; AICD; amyloid intracellular domain; BACE-1; β-secretase beta-site amyloid precursor protein-cleavi
Keywords: Progressive supranuclear palsy; Tauopathies; MAPT;
Keywords: Cognitive enhancer; Histone deacetylases; Epigenetic; Chromatin; Acetylation; CREB; AcH4K12; acetylated histone H4 lysine 12; AcH3K9; acetylated histone lysine 9; Bdnf; brain-derived neurotrophic factor; CRE; cAMP response element; CREB; cAMP response ele
Keywords: Cognitive function; Motor function; SNCA; MAPT; Parkinson's disease
Keywords: Multiple system atrophy; MAPT; Association study; Genetics
Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants
Keywords: Genetics; MAPT; Progressive supranuclear palsy;
Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study
Keywords: Fatty acids; MAPT; Omega-3; Physical performance; SPPB;
Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI
Keywords: Frontotemporal dementia; MAPT protein, human; GRN protein, human; C9orf72, human; Diffusion Tensor Imaging; Resting-state functional MRI; Multimodal MRI; classification; machine learning; 3DT1w; 3-dimensional T1-weighted; AUC; Area under the receiver oper
Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease
Keywords: ACN; Acetonitrile; AD; Alzheimer's disease; AMF; ammonium formate; ATP; adenosine-triphosphate; BzATP; 3â²-O-(4-Benzoyl)benzoyl ATP, strong agonist for P2X7 receptor; CNS; central nervous system; DMEM; Dulbecco's Modified Eagle's Medium; DMF; dimethylfor
Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation
Keywords: Alzheimer disease (AD); Frontotemporal dementia (FTD); Tau pathology; Calreticulin; Caspase; Cathepsin; Necrosis; Insulin-signaling; 2N4R-Tau; largest isoform of human Tau in CNS (441 residues 2 inserts +4 repeats) accession: NP_005901.2 amino acid number
Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner
Keywords: 5-HT; 5-hydroxytryptamine; Aβ; β-amyloid; ABCA8; ATP binding cassette subfamily A member 8; AD; Alzheimer's disease; ADP; adenosine diphosphate; AGD; argyrophilic grain disease; ALS; amyotrophic lateral sclerosis; AMBRA-1; autophagy and beclin 1 regul
Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America
Keywords: FTD; MAPT; P301L; Cognition; CBS;
DCTN1-related neurodegeneration: Perry syndrome and beyond
Keywords: Atypical parkinsonism; DCTN1; Dynactin; FTD; Genetics; TDP-43; Perry syndrome; PSP; Review; ALS; amyotrophic lateral sclerosis; CAP-Gly; cytoskeleton-associated protein, glycine-rich; DCTN1; dynactin 1; FTD; frontotemporal dementia; HD; Huntington's dis
Tau mRNA 3â²UTR-to-CDS ratio is increased in Alzheimer disease
Keywords: MAPT; Microtubule associated protein tau; UTR; untranslated region; CDS; coding DNA sequence; mRNA; messenger RNA; mTOR; mammalian target of rapamycin; 5â²TOP; 5â² terminal oligopyrimidine; RIN; RNA integrity number; Tau (MAPT); 3â²UTR; CDS; mRNA; Alzh
Analyses MAPT, GRN, and C9orf72 mutations in Chinese patients with frontotemporal dementia
Keywords: Frontotemporal dementia; MAPT; GRN; C9orf72;
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
Keywords: Dementia with Lewy bodies; Lewy body disease; Genetic association study; MAPT; tau protein;
Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients
Keywords: PD; Parkinson's disease; MAPT; the microtubule-associated protein tau gene; GBA; the glucocerebrosidase gene; SMPD1; the sphingomyelin phosphodiesterase 1, âacid lysosomal gene; MTHFR; the methylenetetrahydrofolate reductase gene; dbSNP; database of s
Gene regulatory effects of disease-associated variation in the NRF2 network
Keywords: NRF2; NFE2L2; ARE; Oxidative stress; Polymporphism; Mutation; GWAS; Cancer; MAPT; Parkinson disease;
Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression
Keywords: Parkinson disease; Age at onset; Motor progression; GBA; SNCA; MAPT;
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
Keywords: Parkinson's disease; Dementia; Aging; Memory; fMRI; Hippocampus; MAPT; Genetics; Tau; Cognitive impairment; Picture recognition;
Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion
Keywords: Frontotemporal dementia; FTLD; FTLD-ALS; ALS; PGRN; C9ORF72; MAPT; TDP-43; Loss-of-function; RNA foci; Dipeptide repeats; Démence lobaire frontotemporale; DLFT; Sclérose latérale amyotrophique; SLA; DLFT-SLA; PGRN; C9ORF72; MAPT; TDP-43; Perte de fonct
MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals
Keywords: Parkinson's disease; Genetic association; MAPT; LRRK2; Interaction;
Role of the Extended MAPT Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease
Keywords: Delusions; hallucinations; psychosis; Alzheimer disease; MAPT; tau;
Decision trees for the analysis of genes involved in Alzheimer׳s disease pathology
Keywords: Gene expression; Microarray; MMSE; MAPT;
Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia
Keywords: C9orf72; Frontotemporal dementia; GRN; Korean; MAPT; Mutation;
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study
Keywords: Alzheimer's disease; Genetics; Association; Rate of progression; PPP3R1; MAPT;
Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
Keywords: Alzheimer's disease; Neurodegenerative dementia; APP; PSEN1; PSEN2; MAPT; GRN; PRNP; Exome sequencing;
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy
Keywords: TDP-43; Inclusion body myositis; RNA; MAPT; hnRNP; Amyotrophic lateral sclerosis;
Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson’s disease: A meta-analysis
Keywords: Parkinson’s disease; MAPT; STH; Polymorphism; Meta-analysis
The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
Keywords: Parkinson's disease; LRRK2; SNCA; MAPT; Interaction; Genetics;
Pallidonigroluysian atrophy associated with p.A152T variant in MAPT
Keywords: Pallidonigroluysian; MAPT; A152T; Progressive supranuclear palsy; Eyelid apraxia; Tau;
An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease
Keywords: Alzheimer's disease; Progressive supranuclear palsy; Polymorphisms; MOBP; MAPT; EIF2AK3;
TDP-43 pathology in a patient carrying G2019S LRRK2Â mutation and a novel p.Q124E MAPT
Keywords: LRRK2; MAPT; Parkinson's disease; TDP-43; tau;
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS
Keywords: MAPT; PGRN; C9orf72; De novo; Abnormal eye movements;
PI3-kinase/Akt/mTOR signaling: Impaired on/off switches in aging, cognitive decline and Alzheimer's disease
Keywords: AD; Alzheimer's disease; Aβ; amyloid-β; APP; amyloid precursor protein; 4EBP1; eukaryotic translation initiation factor 4E (eIF-4E)-binding protein-1; FOXO; Forkhead box-O class transcription factors; FMRP; Fragile-X mental retardation protein; GSK3β;
CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease
Keywords: CELF; CUG-BP, Elav-like family; DM1; Myotonic dystrophy type 1; MBNL; Muscle blind-like; SCA; Spinocerebellar ataxia; SMA; Spinal muscular atrophy; SMN; Survival motor neuron; SBMA; Spinal and bulbar muscular atrophy; CLIP; Crosslinking immunoprecipitatio